1. Home
  2. UG vs ACHL Comparison

UG vs ACHL Comparison

Compare UG & ACHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UG
  • ACHL
  • Stock Information
  • Founded
  • UG 1942
  • ACHL 2016
  • Country
  • UG United States
  • ACHL United Kingdom
  • Employees
  • UG N/A
  • ACHL N/A
  • Industry
  • UG Package Goods/Cosmetics
  • ACHL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • UG Consumer Discretionary
  • ACHL Health Care
  • Exchange
  • UG Nasdaq
  • ACHL Nasdaq
  • Market Cap
  • UG 43.9M
  • ACHL 40.4M
  • IPO Year
  • UG N/A
  • ACHL 2021
  • Fundamental
  • Price
  • UG $9.55
  • ACHL $1.05
  • Analyst Decision
  • UG
  • ACHL Hold
  • Analyst Count
  • UG 0
  • ACHL 3
  • Target Price
  • UG N/A
  • ACHL $2.83
  • AVG Volume (30 Days)
  • UG 19.4K
  • ACHL 142.6K
  • Earning Date
  • UG 11-08-2024
  • ACHL 11-14-2024
  • Dividend Yield
  • UG 6.28%
  • ACHL N/A
  • EPS Growth
  • UG 38.11
  • ACHL N/A
  • EPS
  • UG 0.76
  • ACHL N/A
  • Revenue
  • UG $12,312,275.00
  • ACHL N/A
  • Revenue This Year
  • UG N/A
  • ACHL N/A
  • Revenue Next Year
  • UG N/A
  • ACHL N/A
  • P/E Ratio
  • UG $12.59
  • ACHL N/A
  • Revenue Growth
  • UG 11.51
  • ACHL N/A
  • 52 Week Low
  • UG $6.75
  • ACHL $0.63
  • 52 Week High
  • UG $16.25
  • ACHL $1.76
  • Technical
  • Relative Strength Index (RSI)
  • UG 24.16
  • ACHL 60.22
  • Support Level
  • UG $9.00
  • ACHL $0.99
  • Resistance Level
  • UG $10.65
  • ACHL $1.12
  • Average True Range (ATR)
  • UG 0.84
  • ACHL 0.04
  • MACD
  • UG -0.32
  • ACHL -0.00
  • Stochastic Oscillator
  • UG 10.68
  • ACHL 54.84

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

About ACHL Achilles Therapeutics plc

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.

Share on Social Networks: